blueearthdiagnosticsltd

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Description:

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Contacts:

Phillip Davis, MD

phillip.davis@blueearthdx.com

+1 843 367 4652

Evgenia Perkins

evgenia.perkins@blueearthdx.com

+1 913 957 6499

Flotufolastat F-18

Isotope(s):
Target(s):
  • PSMA

Piflufolastat F-18

Isotope(s):
Target(s):
  • PSMA

Patient Education


Patient Education Not Yet Provided

Publications


Publications Not Yet Provided

Locations


Not yet provided. Contact Phillip Davis, MD for more information.

+1 843 367 4652

phillip.davis@blueearthdx.com

XCancer

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468